These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
637 related articles for article (PubMed ID: 28592388)
1. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling. Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling. Pal SK; Choueiri TK; Wang K; Khaira D; Karam JA; Van Allen E; Palma NA; Stein MN; Johnson A; Squillace R; Elvin JA; Chmielecki J; Yelensky R; Yakirevich E; Lipson D; Lin DI; Miller VA; Stephens PJ; Ali SM; Ross JS Eur Urol; 2016 Sep; 70(3):516-21. PubMed ID: 26149668 [TBL] [Abstract][Full Text] [Related]
3. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features. Ren Q; Wang L; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB Am J Surg Pathol; 2018 Jun; 42(6):767-777. PubMed ID: 29462091 [TBL] [Abstract][Full Text] [Related]
4. In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma. Yang M; Hlady RA; Zhou D; Ho TH; Robertson KD Cancer Med; 2019 Sep; 8(12):5760-5768. PubMed ID: 31361072 [TBL] [Abstract][Full Text] [Related]
6. Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study. Liu K; Ren Y; Pang L; Qi Y; Jia W; Tao L; Hu Z; Zhao J; Zhang H; Li L; Yue H; Han J; Liang W; Hu J; Zou H; Yuan X; Li F Int J Clin Exp Pathol; 2015; 8(7):8311-35. PubMed ID: 26339402 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy. Hacking SM; Pavlick D; Wang Y; Carneiro BA; Mullally M; Lu S; Canepa M; Bratslavsky G; Jacob J; Necchi A; Spiess PE; Wang L; Yakirevich E; Ross J Oncologist; 2023 Jul; 28(7):e508-e519. PubMed ID: 36917021 [TBL] [Abstract][Full Text] [Related]
8. MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features. Denize T; Just PA; Sibony M; Blons H; Timsit MO; Drossart T; Jakubowicz D; Broudin C; Morini A; Molina T; Vano Y; Auvray-Kuentz M; Richard S; Mejean A; Gimenez Roqueplo AP; Burnichon N; Verkarre V Mod Pathol; 2021 Mar; 34(3):647-659. PubMed ID: 32770124 [TBL] [Abstract][Full Text] [Related]
9. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis. Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive genomic profiling of malignant phyllodes tumors of the breast. Nozad S; Sheehan CE; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Schrock AB; Hirshfield KM; Ali N; Ganesan S; Ali SM; Miller VA; Stephens PJ; Ross JS; Chung JH Breast Cancer Res Treat; 2017 Apr; 162(3):597-602. PubMed ID: 28210881 [TBL] [Abstract][Full Text] [Related]
17. Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines. Yang Y; Ricketts CJ; Vocke CD; Killian JK; Padilla-Nash HM; Lang M; Wei D; Lee YH; Wangsa D; Sourbier C; Meltzer PS; Ried T; Merino MJ; Metwalli AR; Ball MW; Srinivasan R; Linehan WM Genes Chromosomes Cancer; 2021 Jun; 60(6):434-446. PubMed ID: 33527590 [TBL] [Abstract][Full Text] [Related]
18. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications. Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations. Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations. Ross JS; Wang K; Khaira D; Ali SM; Fisher HA; Mian B; Nazeer T; Elvin JA; Palma N; Yelensky R; Lipson D; Miller VA; Stephens PJ; Subbiah V; Pal SK Cancer; 2016 Mar; 122(5):702-11. PubMed ID: 26651075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]